Results 71 to 80 of about 1,758 (156)

Chronic kidney disease and valvular heart disease: State of the art

open access: yesPhysiological Reports, Volume 13, Issue 18, September 2025.
Abstract Chronic kidney disease (CKD) and valvular heart disease (VHD) frequently coexist and are associated with a significant increase in morbidity and mortality. Their interplay is complex and multifactorial, involving shared pathophysiological mechanisms such as chronic inflammation, mineral and bone disorder, vascular and valvular calcification ...
S. Saltarocchi   +6 more
wiley   +1 more source

Emergent Cardiac Surgery After Transcatheter Structural Heart Procedures: Narrative Review

open access: yesCatheterization and Cardiovascular Interventions, Volume 106, Issue 1, Page 136-143, July 1, 2025.
ABSTRACT Transcatheter structural heart procedures have become standard therapy for elderly patients with high surgical risk. Over time, these procedures have significantly increased worldwide, accompanied by a concomitant reduction of major complications, including those requiring emergent cardiac surgery (ECS).
Miriam Compagnone   +7 more
wiley   +1 more source

Impact of the Commercial Introduction of Transcatheter Mitral Valve Repair on Mitral Surgical Practice

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background There has been uncertainty regarding the effect of transcatheter mitral valve repair (TMVr) with MitraClip on cardiac surgical practice. Our aim was to examine the impact of the commercial introduction of TMVr to a comprehensive mitral program.
Hiroki Niikura   +10 more
doaj   +1 more source

First Experience With a Novel Self‐Expandable Valve for Mitral Annular Calcification Guided by Three‐Dimensional Printing

open access: yesCatheterization and Cardiovascular Interventions, Volume 105, Issue 4, Page 855-860, March 1, 2025.
ABSTRACT Transcatheter mitral valve replacement (TMVR) may emerge as a surgical alternative for high‐risk patients with severe mitral annular calcification (MAC), yet several questions remain to be addressed. We present the case of a 67‐year‐old high‐risk female patient with severe MAC (MAC score = 8) and mitral stenosis (effective orifice area = 121.3 
Yiwei Wang   +3 more
wiley   +1 more source

Temporal Trends and Outcomes of Transcatheter Mitral Valve Repair and Surgical Mitral Valve Intervention

open access: yes, 2020
Background: There is a paucity of data regarding the contemporary changes in the uptake and outcomes of transcatheter mitral valve repair (TMVR) and surgical mitral valve repair/replacement (SMVR).
Elgendy, Islam Y.   +11 more
core   +1 more source

2024 update in heart failure

open access: yesESC Heart Failure, Volume 12, Issue 1, Page 8-42, February 2025.
Abstract In the last years, major progress has occurred in heart failure (HF) management. The 2023 ESC focused update of the 2021 HF guidelines introduced new key recommendations based on the results of the last years of science. First, two drugs, sodium–glucose co‐transporter‐2 (SGLT2) inhibitors and finerenone, a novel nonsteroidal, selective ...
Alberto Beghini   +12 more
wiley   +1 more source

Accuracy of Three‐Dimensional Neo Left Ventricular Outflow Tract Simulations With Transcatheter Mitral Valve Replacement in Different Mitral Phenotypes

open access: yesCatheterization and Cardiovascular Interventions, Volume 105, Issue 1, Page 249-257, January 1, 2025.
ABSTRACT Background Transcatheter mitral valve replacement (TMVR) is emerging in the context of annular calcification (valve‐in‐MAC; ViMAC), failing surgical mitral annuloplasty (mitral‐valve‐in‐ring; MViR) and failing mitral bioprosthesis (mitral‐valve‐in‐valve; MViV).
Mark M. P. van den Dorpel   +10 more
wiley   +1 more source

A More Efficient Method of Patient Evaluation for TMVR: Planning for Best- and Worst-Case Position

open access: yes, 2019
Background: Left ventricular outflow tract (LVOT) obstruction is a life-threatening complication after transcatheter mitral valve replacement (TMVR), occurring in ∼10% of patients.
Schrot, J   +4 more
core   +1 more source

Outcomes after transcatheter mitral valve implantation in valve‐in‐valve, valve‐in‐ring, and valve‐in‐mitral annular calcification

open access: yesCatheterization and Cardiovascular Interventions, Volume 104, Issue 4, Page 837-852, October 1, 2024.
Abstract Aims We aimed to evaluate transcatheter mitral valve implantation (TMVI) using predominantly balloon‐expandable transcatheter heart valves (THV) in patients with a landing zone for a percutaneously delivered prosthesis. Background Patients with a degenerated mitral valve bioprosthesis, annuloplasty ring, and mitral annulus calcification (MAC ...
Hector A. Alvarez‐Covarrubias   +14 more
wiley   +1 more source

Antithrombotic Therapy Following Structural Heart Disease Interventions: Current Status and Future Directions

open access: yesReviews in Cardiovascular Medicine
Interventions in structural heart disease cover many catheter-based procedures for congenital and acquired conditions including valvular diseases, septal defects, arterial or venous obstructions, and fistulas.
Andreas Mitsis   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy